We’re launching Lyria 3.5 in Google Flow Music, with advances across musicality, lyrics, vocals, and creative control
deepmind.google·6d ago
AI Engineering
Hacker News·Jul 1·5 min read
Single Dose of Frog-Derived Gut Bacterium Eradicates 100% of Tumors in Mice
TL;DR
Current cancer treatments often fail to achieve complete tumor eradication and can have significant side effects. Researchers discovered a gut bacterium, Ewingella americana, that completely eliminated tumors in mice after a single intravenous dose.
✦ Why It Matters
Engineers and researchers can explore the use of living organisms in cancer therapies for enhanced efficacy and safety.
Key Takeaways
- Investigate the potential of gut bacteria in cancer treatment.
- Explore dual-action therapies combining direct destruction and immune activation.
- Consider the implications of living organisms in drug development.
- Analyze the safety profiles of novel bacterial therapies.
Full Summary
Cancer treatments like chemotherapy and immunotherapy often leave residual tumors and can cause harmful side effects. A new study identified Ewingella americana, a gut bacterium from amphibians, which was administered intravenously to mice with colorectal cancer.
This bacterium preferentially accumulates in low-oxygen tumor environments, where it proliferates and directly destroys cancer cells while stimulating an immune response. Within 24 hours, bacterial levels in tumors increased by approximately 3,000-fold, leading to complete tumor elimination in all treated mice.
Notably, there was no recurrence of tumors upon re-exposure to cancer cells, indicating long-lasting immune protection. This dual-action mechanism of direct cytotoxicity and immune activation sets E. americana apart from traditional therapies, which typically rely on a single action.
These findings suggest a potential new avenue for cancer treatment that could improve outcomes and reduce side effects.